FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hugh Barrett

Research Profile

Chemicals & Drugs

Concepts & Ideas

Kinetics

Disorders

Anatomy

Livers

Co-author Network

Publications

TOP 3
Esther M M Ooi; Dennis L Sprecher; Gerald F Watts; Dick C Chan; Hugh Barrett
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Esther M M Ooi; Doris T Chan; Gerald F Watts; Dick C Chan; Theodore W K Ng; Gursharan Dogra; Ashley Irish; Hugh Barrett
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
Bronwyn G A Stuckey; Hugh Barrett; J M Wagner; R A Hampton; Dick C Chan; S J Brown; Gerald F Watts
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hugh Barrett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Esther M M Ooi; Dennis L Sprecher; Gerald F Watts; Dick C Chan; Hugh Barrett
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
The Journal of clinical endocrinology and metabolism 2011;96(10):E1568-76.
2011: Esther M M Ooi; Doris T Chan; Gerald F Watts; Dick C Chan; Theodore W K Ng; Gursharan Dogra; Ashley Irish; Hugh Barrett
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
Journal of lipid research 2011;52(4):794-800.
2010: Bronwyn G A Stuckey; Hugh Barrett; J M Wagner; R A Hampton; Dick C Chan; S J Brown; Gerald F Watts
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
Clinical endocrinology 2010;73(4):497-501.
2010: Dick C Chan; Gerald F Watts; Seng Khee Gan; Esther M M Ooi; Hugh Barrett
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.
Diabetes care 2010;33(5):1134-9.
2010: Dick C Chan; Gerald F Watts; SengKhee Gan; Annette T Y Wong; Esther M M Ooi; Hugh Barrett
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(5):1043-50.
2010: Esther M M Ooi; Gerald F Watts; Dick C Chan; Lars B Nielsen; Peter Plomgaard; Bjorn Dahlbäck; Hugh Barrett
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Atherosclerosis 2010;210(1):326-30.
2010: Theodore W K Ng; Esther M M Ooi; Gerald F Watts; Dick C Chan; Hugh Barrett
Genetic determinants of apolipoprotein B-100 kinetics.
Current opinion in lipidology 2010;21(2):141-7.
2010: Theodore W K Ng; Dick C Chan; Hugh Barrett; Gerald F Watts
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Clinical science (London, England : 1979) 2010;118(1):79-85.
2009: Dick C Chan; Gilles Lambert; Hugh Barrett; Kerry-Anne Rye; Esther M M Ooi; Gerald F Watts
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?
Clinical chemistry 2009;55(11):2049-52.
2009: Dick C Chan; Gerald F Watts; Esther M M Ooi; Kerry-Anne Rye; Juying Ji; Anthony G Johnson; Hugh Barrett
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.
Diabetes care 2009;32(11):2111-3.
2009: Dick C Chan; Hugh Barrett; Esther M M Ooi; Juying Ji; Doris T Chan; Gerald F Watts
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
The Journal of clinical endocrinology and metabolism 2009;94(3):989-97.
2008: Dick C Chan; Gerald F Watts; Theodore W K Ng; Shizuya Yamashita; Hugh Barrett
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
European journal of clinical investigation 2008;38(10):743-51.
2008: Nirupa R Matthan; Susan M Jalbert; Hugh Barrett; Gregory G Dolnikowski; Ernst Schaefer; Alice H Lichtenstein
Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1838-43.
2008: Emma M Allister; Erin E Mulvihill; Hugh Barrett; Jane Y Edwards; Lindsey P Carter; Murray W Huff
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
Journal of lipid research 2008;49(10):2218-29.
2008: Dick C Chan; Gerald F Watts; Esther M M Ooi; Juying Ji; Anthony G Johnson; Hugh Barrett
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1831-7.
2008: Stefania Lamon-Fava; Margaret R Diffenderfer; Hugh Barrett; Aaron Buchsbaum; Mawuli Nyaku; Katalin V Horvath; Bela F Asztalos; Seiko Otokozawa; Masumi Ai; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Ernst Schaefer
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(9):1672-8.
2008: Gerald F Watts; Hugh Barrett; Dick C Chan
HDL metabolism in context: looking on the bright side.
Current opinion in lipidology 2008;19(4):395-404.
2008: Esther M M Ooi; Gerald F Watts; Dick C Chan; Meifania M Chen; Paul J Nestel; Dmitri Sviridov; Hugh Barrett
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.
Diabetes care 2008;31(8):1656-61.
2008: Dick C Chan; Gerald F Watts; Jian Wang; Robert A Hegele; Frank M Van Bockxmeer; Hugh Barrett
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
Clinical endocrinology 2008;69(1):45-51.
2008: Esther M M Ooi; Hugh Barrett; Dick C Chan; Gerald F Watts
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
Clinical science (London, England : 1979) 2008;114(10):611-24.
2008: Dmitri Sviridov; Anh Hoang; Esther Ooi; Gerald Watts; Hugh Barrett; Paul Nestel
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.
Atherosclerosis 2008;197(2):732-9.
2008: John S Millar; Margaret E Brousseau; Margaret R Diffenderfer; Hugh Barrett; Francine K Welty; Jeffrey S Cohn; Aisha Wilson; Megan L Wolfe; Chorthip Nartsupha; Peter M Schaefer; Andres G Digenio; James P Mancuso; Gregory G Dolnikowski; Ernst Schaefer; Daniel J Rader
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
Journal of lipid research 2008;49(3):543-9.
2008: Esther M M Ooi; Hugh Barrett; Dick C Chan; Paul J Nestel; Gerald F Watts
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
Atherosclerosis 2008;197(1):139-46.
2008: Esther M M Ooi; Gerald F Watts; Paul J Nestel; Dmitri Sviridov; Anh Hoang; Hugh Barrett
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2008;93(2):430-7.
2008: Dick C Chan; Minh N Nguyen; Gerald F Watts; Hugh Barrett
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
The Journal of clinical endocrinology and metabolism 2008;93(2):557-64.
2007: Peter L Gibbons; Kevin Batty; Hugh Barrett; Timothy Davis; Kenneth F Ilett
Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.
International journal for parasitology 2007;37(14):1569-76.
2007: Theodore W K Ng; Gerald F Watts; Hugh Barrett; Kerry-Anne Rye; Dick C Chan
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
Diabetes care 2007;30(11):2945-50.
2007: John R Burnett; Shumei Zhong; Zhenghui Gordon Jiang; Amanda J Hooper; Eric A Fisher; Roger S McLeod; Yang Zhao; Hugh Barrett; Robert A Hegele; Frank M Van Bockxmeer; Hongyu Zhang; Dennis E Vance; C James McKnight; Zemin Yao
Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
The Journal of biological chemistry 2007;282(33):24270-83.
2007: Stefania Lamon-Fava; Margaret R Diffenderfer; Hugh Barrett; Aaron Buchsbaum; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Katalin Horvath; Bela F Asztalos; Valeria Zago; Ernst Schaefer
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism.
Journal of lipid research 2007;48(8):1746-53.
2007: C Roger Goucke; L Peter Hackett; Hugh Barrett; Kenneth F Ilett
Blood concentrations of enflurane before, during, and after hypothermic cardiopulmonary bypass.
Journal of cardiothoracic and vascular anesthesia 2007;21(2):218-23.
2007: Amanda J Hooper; Ken Robertson; Hugh Barrett; Klaus G Parhofer; Frank M Van Bockxmeer; John R Burnett
Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
The Journal of clinical endocrinology and metabolism 2007;92(4):1474-8.
2007: Dawn E Telford; Brian G Sutherland; Jane Y Edwards; Joseph D Andrews; Hugh Barrett; Murray W Huff
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.
Journal of lipid research 2007;48(3):699-708.
2007: Esther M M Ooi; Gerald F Watts; Hugh Barrett; Dick C Chan; Peter M Clifton; Juying Ji; Paul J Nestel
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Asia Pacific journal of clinical nutrition 2007;16(4):624-31.
2006: Esther M M Ooi; Gerald F Watts; Juying Ji; Kerry-Anne Rye; Anthony G Johnson; Dick C Chan; Hugh Barrett
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
Clinical endocrinology 2006;65(6):752-9.
2006: Dick C Chan; Gerald F Watts; Theodore W K Ng; J Hua; S Song; Hugh Barrett
Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.
Diabetes, obesity & metabolism 2006;8(6):698-702.
2006: Gerald F Watts; Dick C Chan; Esther M M Ooi; Paul J Nestel; Lawrence J Beilin; Hugh Barrett
Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
Clinical and experimental pharmacology & physiology 2006;33(9):877-82.
2006: Esther M M Ooi; Gerald F Watts; Maryam Sadat Farvid; Dick C Chan; M C Allen; S R Zilko; Hugh Barrett
High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
European journal of clinical investigation 2006;36(9):626-32.
2006: Gerald F Watts; Juying Ji; Dick C Chan; Esther M M Ooi; Anthony G Johnson; Kerry-Anne Rye; Hugh Barrett
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Clinical science (London, England : 1979) 2006;111(3):193-9.
2006: Timothy Davis; Juliana Hamzah; Kenneth F Ilett; Harin A Karunajeewa; John C Reeder; Kevin Batty; Sara Hackett; Hugh Barrett
In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs.
Antimicrobial agents and chemotherapy 2006;50(8):2883-5.
2006: Hugh Barrett; Dick C Chan; Gerald F Watts
Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.
Journal of lipid research 2006;47(8):1607-19.
2006: Klaus G Parhofer; Hugh Barrett
Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.
Journal of lipid research 2006;47(8):1620-30.
2006: Dick C Chan; Gerald F Watts; Minh N Nguyen; Hugh Barrett
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.
The American journal of clinical nutrition 2006;84(1):37-43.
2006: Emma Allister; Anthony P James; Gerald F Watts; Hugh Barrett; John C L Mamo
Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
European journal of clinical investigation 2006;36(7):489-96.
2006: John S Millar; Margaret E Brousseau; Margaret R Diffenderfer; Hugh Barrett; Francine K Welty; Aisha Faruqi; Megan L Wolfe; Chorthip Nartsupha; Andres G Digenio; James P Mancuso; Gregory G Dolnikowski; Ernst Schaefer; Daniel J Rader
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(6):1350-6.
2006: Minh N Nguyen; Dick C Chan; Kevin P Dwyer; Paul Bolitho; Gerald F Watts; Hugh Barrett
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma.
Journal of lipid research 2006;47(6):1274-80.
2006: Regina E Dinkel; Hugh Barrett; Thomas Demant; Klaus G Parhofer
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16(3):215-21.
2006: Patrick Kee; Daniela Caiazza; Kerry-Anne Rye; Hugh Barrett; L A Morehouse; Philip J Barter
Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(4):884-90.
2006: Dick C Chan; Gerald F Watts; Minh N Nguyen; Hugh Barrett
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):590-6.
2006: Juying Ji; Gerald F Watts; Anthony G Johnson; Dick C Chan; Esther M M Ooi; Kerry-Anne Rye; Adrian P Serone; Hugh Barrett
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
The Journal of clinical endocrinology and metabolism 2006;91(3):973-9.
2006: Dick C Chan; Hugh Barrett; Gerald F Watts
Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders.
Current opinion in lipidology 2006;17(1):28-36.
2006: Stefania Lamon-Fava; Borbala Postfai; Margaret R Diffenderfer; Carl deLuca; John O'Connor; Francine K Welty; Gregory G Dolnikowski; Hugh Barrett; Ernst Schaefer
Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):385-91.
2005: John R Burnett; Dawn E Telford; Hugh Barrett; Murray W Huff
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Biochimica et biophysica acta 2005;1738(1-3):10-8.
2005: Theodore W K Ng; Gerald F Watts; Bronwyn G A Stuckey; Helena L Ching; D C F Chan; Yoshiaki Uchida; Naohiko Sakai; Shizuya Yamashita; Ian J Martins; Trevor G Redgrave; Hugh Barrett
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Clinical endocrinology 2005;63(6):650-6.
2005: Dawn E Telford; Sara M Lipson; Hugh Barrett; Brian G Sutherland; Jane Y Edwards; Johannes D Aebi; Henrietta Dehmlow; Olivier H Morand; Murray W Huff
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2608-14.
2005: Dick C Chan; Gerald F Watts; Theodore W K Ng; Yoshiaki Uchida; Naohiko Sakai; Shizuya Yamashita; Hugh Barrett
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Clinical biochemistry 2005;38(9):806-12.
2005: Maryam Sadat Farvid; Theodore W K Ng; Dick C Chan; Hugh Barrett; Gerald F Watts
Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia.
Diabetes, obesity & metabolism 2005;7(4):406-13.
2005: Esther M M Ooi; Gerald F Watts; Maryam Sadat Farvid; Dick C Chan; Michael C Allen; Simon R Zilko; Hugh Barrett
High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Obesity research 2005;13(6):1008-16.
2005: Jennifer L Jenner; Leo J Seman; John S Millar; Stefania Lamon-Fava; Francine K Welty; Gregory G Dolnikowski; Santica M Marcovina; Alice H Lichtenstein; Hugh Barrett; Carl deLuca; Ernst Schaefer
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
Metabolism: clinical and experimental 2005;54(3):361-9.
2005: Theodore W K Ng; Gerald F Watts; Maryam Sadat Farvid; Dick C Chan; Hugh Barrett
Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
Diabetes 2005;54(3):795-802.
2005: Dick C Chan; Gerald F Watts; Theodore W K Ng; Yoshiaki Uchida; Naohiko Sakai; Shizuya Yamashita; Hugh Barrett
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
Clinical chemistry 2005;51(3):578-85.
2005: John S Millar; Cyrille Maugeais; Katsunori Ikewaki; Daniel M Kolansky; Hugh Barrett; Elaine C Budreck; Raymond C Boston; Norio Tada; Seibu Mochizuki; Joep C Defesche; James M Wilson; Daniel J Rader
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(3):560-5.
2005: Amanda J Whitfield; Hugh Barrett; Ken Robertson; Marek F Havlat; Frank M Van Bockxmeer; John R Burnett
Liver dysfunction and steatosis in familial hypobetalipoproteinemia.
Clinical chemistry 2005;51(1):266-9.
2004: Kevin D O'Brien; Katherine Lewis; Jens W Fischer; Pamela Johnson; Jin-Yong Hwang; Eleanor A Knopp; Michael G Kinsella; Hugh Barrett; Alan Chait; Thomas N Wight
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis.
Atherosclerosis 2004;177(1):29-35.
2004: Dick C Chan; Gerald F Watts; Hugh Barrett; Amanda J Whitfield; Frank M Van Bockxmeer
ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(11):2188-91.
2004: Amanda J Whitfield; Hugh Barrett; Frank M Van Bockxmeer; John R Burnett
Lipid disorders and mutations in the APOB gene.
Clinical chemistry 2004;50(10):1725-32.
2004: Francine K Welty; Alice H Lichtenstein; Hugh Barrett; Gregory G Dolnikowski; Ernst Schaefer
Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1703-7.
2004: Dick C Chan; Hugh Barrett; Gerald F Watts
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
Clinical science (London, England : 1979) 2004;107(3):233-49.
2004: Dick C Chan; Hugh Barrett; Gerald F Watts
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.
Clinical science (London, England : 1979) 2004;107(3):221-32.
2004: Harin A Karunajeewa; Kenneth F Ilett; Kitiya Dufall; Adedayo Kemiki; Moses J Bockarie; Michael P Alpers; Hugh Barrett; Paolo Vicini; Timothy Davis
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
Antimicrobial agents and chemotherapy 2004;48(8):2966-72.
2004: H Christian Geiss; S Bremer; Hugh Barrett; Carsten Otto; Klaus G Parhofer
In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis.
Journal of lipid research 2004;45(8):1459-67.
2004: Nirupa R Matthan; Francine K Welty; Hugh Barrett; Carrie Harausz; Gregory G Dolnikowski; John S Parks; Robert H Eckel; Ernst Schaefer; Alice H Lichtenstein
Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(6):1092-7.
2004: Lisa R Tannock; Peter Little; Christina Tsoi; Hugh Barrett; Thomas N Wight; Alan Chait
Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.
Diabetologia 2004;47(5):837-43.
2004: Berthil H C M T Prinsen; ton rabelink; Johannes A Romijn; Peter H Bisschop; Martina M J de Barse; Jose de Boer; Timon W van Haeften; Hugh Barrett; Ruud Berger; Monique G M de Sain-Van Der Velden
A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
Kidney international 2004;65(3):1064-75.
2004: Dick C Chan; Hugh Barrett; Gerald F Watts
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004;25(1):31-48.
2004: Dick C Chan; Gerald F Watts; Andrei V Sussekov; Hugh Barrett; Zhaojun Yang; Jianmin Hua; Swithin Song
Adipose tissue compartments and insulin resistance in overweight-obese Caucasian men.
Diabetes research and clinical practice 2004;63(2):77-85.
2003: Amanda J Whitfield; A D Marais; K Robertson; Hugh Barrett; Frank M Van Bockxmeer; John R Burnett
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
Human mutation 2003;22(2):178.
2003: Gerald F Watts; Dick C Chan; Hugh Barrett; Frans O'Neill; Gilbert R Thompson
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(7):862-5.
2003: Berthil H C M T Prinsen; Johannes A Romijn; Peter H Bisschop; Martina M J de Barse; Hugh Barrett; Mariëtte Ackermans; Ruud Berger; ton rabelink; Monique G M de Sain-Van Der Velden
Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans.
Journal of lipid research 2003;44(7):1341-8.
2003: Dick C Chan; Gerald F Watts; Hugh Barrett; V Burke
Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men.
QJM : monthly journal of the Association of Physicians 2003;96(6):441-7.
2003: Klaus G Parhofer; Ester Laubach; Hugh Barrett
Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.
Journal of lipid research 2003;44(6):1192-8.
2003: Robert A Hegele; Bernard Zinman; Anthony J G Hanley; Stewart B Harris; Hugh Barrett; Henian Cao
Genes, environment and Oji-Cree type 2 diabetes.
Clinical biochemistry 2003;36(3):163-70.
2003: Dick C Chan; Gerald F Watts; Hugh Barrett
Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
Diabetes, obesity & metabolism 2003;5(3):202-6.
2003: Dawn E Telford; Jane Y Edwards; Sara M Lipson; Brian G Sutherland; Hugh Barrett; John R Burnett; Elaine Krul; Bradley T Keller; Murray W Huff
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
Journal of lipid research 2003;44(5):943-52.
2003: Dick C Chan; Gerald F Watts; Hugh Barrett; Frans O'Neill; Gilbert R Thompson
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Obesity research 2003;11(4):591-6.
2003: Timothy Davis; David A Syed; Kenneth F Ilett; Hugh Barrett
Toxicity related to chloroquine treatment of resistant vivax malaria.
The Annals of pharmacotherapy 2003;37(4):526-9.
2003: Dick C Chan; Gerald F Watts; Hugh Barrett; Frans O'Neill; Trevor G Redgrave; Gilbert R Thompson
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
Clinical science (London, England : 1979) 2003;104(4):383-8.
2003: Cheryl A Dane-Stewart; Gerald F Watts; Hugh Barrett; Bronwyn G A Stuckey; John C L Mamo; Ian J Martins; Trevor G Redgrave
Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Clinical endocrinology 2003;58(4):415-20.
2003: Helena L Ching; G F Watts; Satvinder S Dhaliwal; Hugh Barrett; Bronwyn G A Stuckey
Vascular function of forearm microcirculation in postmenopausal women with type 2 diabetes: potential benefit of hormone replacement therapy?
Climacteric : the journal of the International Menopause Society 2003;6(1):31-7.
2003: Gerald F Watts; Hugh Barrett; Juying Ji; Adrian P Serone; Dick C Chan; Kevin D Croft; Franziska Loehrer; Anthony G Johnson
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Diabetes 2003;52(3):803-11.
2003: Nica M Borradaile; Linda E de Dreu; Hugh Barrett; Colleen D Behrsin; Murray W Huff
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
Biochemistry 2003;42(5):1283-91.
2003: Anthony P James; Gerald F Watts; Hugh Barrett; Darrin Smith; Sebely Pal; Dick C Chan; John C L Mamo
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men.
Metabolism: clinical and experimental 2003;52(2):136-41.
2003: Hugh Barrett; Gerald F Watts
Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.
Current opinion in lipidology 2003;14(1):61-8.
2003: Dick C Chan; Gerald F Watts; Trevor A Mori; Hugh Barrett; Trevor G Redgrave; Lawrence J Beilin
Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
The American journal of clinical nutrition 2003;77(2):300-7.
2003: Gerald F Watts; Dick C Chan; Hugh Barrett; Andrei V Susekov; Jianmin Hua; Swithin Song
Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Obesity research 2003;11(1):152-9.
2002: Shirya Rashid; Kristine D Uffelman; Hugh Barrett; Gary F Lewis
Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
Circulation 2002;106(23):2955-60.
2002: Patrick Kee; Kerry-Anne Rye; John L Taylor; Hugh Barrett; Philip J Barter
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1912-7.
2002: Murray W Huff; Dawn E Telford; Jane Y Edwards; John R Burnett; Hugh Barrett; Stephen R Rapp; Nida Napawan; Bradley T Keller
Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1884-91.
2002: Katherine Olin-Lewis; Ronald M Krauss; Michael La Belle; Patricia J Blanche; Hugh Barrett; Thomas N Wight; Alan Chait
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan.
Journal of lipid research 2002;43(11):1969-77.
2002: Berthil H C M T Prinsen; George A Kaysen; Leo W J Klomp; Jose de Boer; Hugh Barrett; Paul J Thornalley; Sinan Battah; Ruud Berger; ton rabelink; Monique G M de Sain-Van Der Velden
Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate.
Clinical biochemistry 2002;35(7):545-53.
2002: Nica M Borradaile; Linda E de Dreu; Hugh Barrett; Murray W Huff
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Journal of lipid research 2002;43(9):1544-54.
2002: Jeffrey S Cohn; Michel Tremblay; Rami Batal; Hélène Jacques; Lyne Veilleux; Claudia Rodriguez; Hugh Barrett; Denise Dubreuil; Madeleine Roy; Lise Bernier; Orval Mamer; Jean Davignon
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia.
Journal of lipid research 2002;43(9):1464-71.
2002: Gerald F Watts; Dick C Chan; Hugh Barrett
Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Metabolism: clinical and experimental 2002;51(9):1206-10.
2002: Dick C Chan; Gerald F Watts; Trevor G Redgrave; Trevor A Mori; Hugh Barrett
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Metabolism: clinical and experimental 2002;51(8):1041-6.
2002: Dick C Chan; Gerald F Watts; Hugh Barrett; Lawrence J Beilin; Trevor G Redgrave; Trevor A Mori
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Diabetes 2002;51(8):2377-86.
2002: Timothy Davis; Tran Quang Binh; Le Thi Anh Thu; Ton That Ai Long; Wayne Johnston; Ken Robertson; Hugh Barrett
Glucose and lactate turnover in adults with falciparum malaria: effect of complications and antimalarial therapy.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2002;96(4):411-7.
2002: Cheryl A Dane-Stewart; Gerald F Watts; John C L Mamo; Hugh Barrett; Ian J Martins; SB Dimmitt; Trevor G Redgrave
Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
European journal of clinical investigation 2002;32(7):493-9.
2002: Dick C Chan; Gerald F Watts; Trevor A Mori; Hugh Barrett; Lawrence J Beilin; Trevor G Redgrave
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity.
European journal of clinical investigation 2002;32(6):429-36.
2002: Dick C Chan; Gerald F Watts; Hugh Barrett; Lawrence J Beilin; Trevor A Mori
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity.
Clinical chemistry 2002;48(6 Pt 1):877-83.
2002: Dick C Chan; Gerald F Watts; Hugh Barrett; Trevor A Mori; Lawrence J Beilin; Trevor G Redgrave
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
The Journal of clinical endocrinology and metabolism 2002;87(5):2283-9.
2002: Dick C Chan; Gerald F Watts; Hugh Barrett; Ian J Martins; Anthony P James; John C L Mamo; Trevor A Mori; Trevor G Redgrave
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Journal of lipid research 2002;43(5):706-12.
2002: Barbara L Triggs-Raine; Robert D Kirkpatrick; Sherrie L Kelly; Lisa Norquay; Peter A Cattini; Kazuya Yamagata; Anthony J G Hanley; Bernard Zinman; Stewart B Harris; Hugh Barrett; Robert A Hegele
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4614-9.
2002: John R Burnett; Hugh Barrett
Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies.
Critical reviews in clinical laboratory sciences 2002;39(2):89-137.
2002: Hugh Barrett; Gerald F Watts
Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism.
Atherosclerosis. Supplements 2002;2(3):1-4.
2002: Shirya Rashid; Hugh Barrett; Kristine D Uffelman; Takehiko Watanabe; Khosrow Adeli; Gary F Lewis
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(3):483-7.
2002: Gerald F Watts; Hugh Barrett
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2002;12(1):36-41.
2002: Kevin P Dwyer; Hugh Barrett; Dick Chan; Jock I Foo; Gerald F Watts; Kevin D Croft
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins.
Journal of lipid research 2002;43(2):344-9.
2002: Dick C Chan; Gerald F Watts; Hugh Barrett; John C L Mamo; Trevor G Redgrave
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Clinical chemistry 2002;48(2):278-83.
2002: Lisa R Tannock; Katherine L Olin; Hugh Barrett; Thomas N Wight; Alan Chait
Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan.
The Journal of clinical endocrinology and metabolism 2002;87(1):35-40.
2001: Gerald F Watts; Dick C Chan; Hugh Barrett; Ian J Martins; Trevor G Redgrave
Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Clinical science (London, England : 1979) 2001;101(6):683-90.
2001: Hugh Barrett; G F Watts
HDL kinetics, fish oils and diabetes.
Atherosclerosis 2001;159(1):243-4.
2001: KW Huggins; Perry L Colvin; Ellen R Burleson; Kathryn Kelley; Janet K Sawyer; Hugh Barrett; Lawrence L Rudel; John S Parks
Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys.
Journal of lipid research 2001;42(9):1457-66.
2001: John C L Mamo; Gerald F Watts; Hugh Barrett; D Smith; Anthony P James; Sebely Pal
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
American journal of physiology. Endocrinology and metabolism 2001;281(3):E626-32.
2001: Gursharan Dogra; N Ward; Kevin D Croft; Trevor A Mori; Hugh Barrett; S E Herrmann; Ashley Irish; Gerald F Watts
Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1626-30.
2001: Gerald F Watts; Hugh Barrett; A D Marais; Cheryl A Dane-Stewart; Ian J Martins; SB Dimmitt; Trevor G Redgrave
Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Atherosclerosis 2001;157(2):519-23.
2001: Molly C Carr; JE Hokanson; Alberto Zambon; Samir S Deeb; Hugh Barrett; Jonathan Q Purnell; John D Brunzell
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
The Journal of clinical endocrinology and metabolism 2001;86(6):2831-7.
2001: Trevor G Redgrave; Gerald F Watts; Ian J Martins; Hugh Barrett; John C L Mamo; SB Dimmitt; A D Marais
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Journal of lipid research 2001;42(5):710-5.
2001: Shirya Rashid; Kristine D Uffelman; Hugh Barrett; P Vicini; Khosrow Adeli; Gary F Lewis
Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits.
Journal of lipid research 2001;42(2):265-71.
2001: Cheryl A Dane-Stewart; Gerald F Watts; John C L Mamo; SB Dimmitt; Hugh Barrett; Trevor G Redgrave
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
European journal of clinical investigation 2001;31(2):113-7.
2001: Katherine L Olin; Susan Potter-Perigo; Hugh Barrett; Thomas N Wight; Alan Chait
Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(1):129-35.
2000: Klaus G Parhofer; Hugh Barrett; Peter Schwandt
Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
The Journal of clinical endocrinology and metabolism 2000;85(11):4224-30.
2000: Timothy Davis; Tran Quang Binh; L T A Thu; R Rossi; PT Danh; Hugh Barrett; J Beilby
Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria.
Clinical science (London, England : 1979) 2000;99(5):433-41.
2000: Klaus G Parhofer; Hugh Barrett; Thomas Demant; Peter Schwandt
Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B.
Journal of lipid research 2000;41(10):1596-603.
2000: Gerald F Watts; P Moroz; Hugh Barrett
Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
Metabolism: clinical and experimental 2000;49(9):1204-10.
2000: Francine K Welty; Alice H Lichtenstein; Hugh Barrett; Jennifer L Jenner; Gregory G Dolnikowski; Ernst Schaefer
Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1807-10.
2000: Rami Batal; Michel Tremblay; Hugh Barrett; Hélène Jacques; A Fredenrich; Orval Mamer; Jean Davignon; Jeffrey S Cohn
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Journal of lipid research 2000;41(5):706-18.
2000: Timothy Davis; F Daly; J P Walsh; Kenneth F Ilett; J P Beilby; Leon J Dusci; Hugh Barrett
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.
British journal of clinical pharmacology 2000;49(3):223-30.
2000: Bernard M Wolfe; Hugh Barrett; Lisanne G Laurier; Murray W Huff
Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women.
Journal of lipid research 2000;41(3):368-75.
2000: J Twisk; Donald L Gillian-Daniel; Angie Tebon; L Wang; Hugh Barrett; Alan D Attie
The role of the LDL receptor in apolipoprotein B secretion.
The Journal of clinical investigation 2000;105(4):521-32.
1999: Katherine L Olin; Susan Potter-Perigo; Hugh Barrett; Thomas N Wight; Alan Chait
Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells.
The Journal of biological chemistry 1999;274(49):34629-36.
1999: Francine K Welty; Alice H Lichtenstein; Hugh Barrett; Gregory G Dolnikowski; Ernst Schaefer
Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2966-74.
1999: John R Burnett; Lisa J Wilcox; Dawn E Telford; SJ Kleinstiver; Hugh Barrett; RS Newton; Murray W Huff
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Endocrinology 1999;140(11):5293-302.
1999: Perry L Colvin; E Moriguchi; Hugh Barrett; John S Parks; Lawrence L Rudel
Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates.
Journal of lipid research 1999;40(10):1782-92.
1999: W Vélez-Carrasco; A H Lichtenstein; Hugh Barrett; Z Sun; Gregory G Dolnikowski; Francine K Welty; Ernst Schaefer
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
Journal of lipid research 1999;40(9):1695-700.
1999: Anne E Sumner; Bonita Falkner; Margaret R Diffenderfer; Hugh Barrett; Julian B Marsh
A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1999;221(4):352-60.
1999: FM Riches; Gerald F Watts; Jianmin Hua; G R Stewart; Rossi P Naoumova; Hugh Barrett
Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
The Journal of clinical endocrinology and metabolism 1999;84(8):2854-61.
1999: John R Burnett; Lisa J Wilcox; Dawn E Telford; SJ Kleinstiver; Hugh Barrett; RS Newton; Murray W Huff
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Journal of lipid research 1999;40(7):1317-27.
1999: Lisa J Wilcox; Hugh Barrett; Murray W Huff
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Journal of lipid research 1999;40(6):1078-89.
1999: Klaus G Parhofer; Hugh Barrett; Peter Schwandt
Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters.
Atherosclerosis 1999;144(1):159-66.
1999: B Lamarche; Kristine D Uffelman; A Carpentier; Jeffrey S Cohn; George Steiner; Hugh Barrett; Gary F Lewis
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.
The Journal of clinical investigation 1999;103(8):1191-9.
1999: Lisa J Wilcox; Hugh Barrett; RS Newton; Murray W Huff
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):939-49.
1998: John R Burnett; Hugh Barrett; P Vicini; DB Miller; Dawn E Telford; SJ Kleinstiver; Murray W Huff
The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(12):1906-14.
1998: John R Burnett; Lisa J Wilcox; Dawn E Telford; SJ Kleinstiver; Hugh Barrett; Murray W Huff
Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Biochimica et biophysica acta 1998;1393(1):63-79.
1998: B Lamarche; Kristine D Uffelman; George Steiner; Hugh Barrett; Gary F Lewis
Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.
Journal of lipid research 1998;39(6):1162-72.
1998: Hugh Barrett; Bradley M Bell; C Cobelli; H Golde; A Schumitzky; Paolo Vicini; David M Foster
SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.
Metabolism: clinical and experimental 1998;47(4):484-92.
1998: Hugh Barrett; K G Parhofer
Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.
Metabolism: clinical and experimental 1998;47(4):478-83.
1998: Paolo Vicini; Hugh Barrett; C Cobelli; David M Foster; A Schumitzky
Approaches to population kinetic analysis with application to metabolic studies.
Advances in experimental medicine and biology 1998;445():103-13.
1997: John R Burnett; Lisa J Wilcox; Dawn E Telford; SJ Kleinstiver; Hugh Barrett; RS Newton; Murray W Huff
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2589-600.
1997: Gary F Lewis; B Lamarche; Kristine D Uffelman; A C Heatherington; M A Honig; Linda Szeto; Hugh Barrett
Clearance of postprandial and lipolytically modified human HDL in rabbits and rats.
Journal of lipid research 1997;38(9):1771-8.
1997: Francine K Welty; Alice H Lichtenstein; Hugh Barrett; Gregory G Dolnikowski; Jose Ordovas; Ernst Schaefer
Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
Journal of lipid research 1997;38(8):1535-43.
1997: Francine K Welty; A H Lichtenstein; Hugh Barrett; Gregory G Dolnikowski; Jose Ordovas; Ernst Schaefer
Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):881-8.
1996: Klaus G Parhofer; Hugh Barrett; Thomas Demant; WO Richter; Peter Schwandt
Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia.
Journal of lipid research 1996;37(11):2383-93.
1996: Klaus G Parhofer; Hugh Barrett; Carlos Aguilar Salinas; Gustav Schonfeld
Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes.
Journal of lipid research 1996;37(4):844-52.
1995: Rampratap S Kushwaha; Hugh Barrett; Catherine Reardon-Alulis; D S Lewis; K Dee Carey; Godfrey S Getz; Henry C McGill
Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
Metabolism: clinical and experimental 1995;44(8):1058-66.
1995: Carlos Aguilar Salinas; Hugh Barrett; Klaus G Parhofer; S G Young; D Tessereau; J Bateman; C Quinn; Gustav Schonfeld
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(1):71-80.
1995: Carlos Aguilar Salinas; Hugh Barrett; J Kelber; J Delmez; Gustav Schonfeld
Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
Journal of lipid research 1995;36(1):188-99.
1994: Murray W Huff; Dawn E Telford; Hugh Barrett; J T Billheimer; P J Gillies
Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1498-508.
1993: David M Foster; Hugh Barrett; G Toffolo; W F Beltz; C Cobelli
Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.
Journal of lipid research 1993;34(12):2193-205.
1993: Klaus G Parhofer; Hugh Barrett; J Dunn; Gustav Schonfeld
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.
The Clinical investigator 1993;71(11):939-46.
1992: Murray W Huff; Dawn E Telford; Hugh Barrett
Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):902-10.
1992: Elaine Krul; Klaus G Parhofer; Hugh Barrett; R D Wagner; Gustav Schonfeld
ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies.
Journal of lipid research 1992;33(7):1037-50.
1992: Klaus G Parhofer; Hugh Barrett; D M Bier; Gustav Schonfeld
Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo.
The Journal of clinical investigation 1992;89(6):1931-7.
1992: Hugh Barrett; Klaus G Parhofer; Gustav Schonfeld
Postmenopausal estrogen and the metabolism of plasma lipoproteins.
The New England journal of medicine 1992;326(14):954-5.
1991: Hugh Barrett; N Baker; P J Nestel
Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
Journal of lipid research 1991;32(5):743-62.
1991: Rampratap S Kushwaha; David M Foster; Hugh Barrett; K Dee Carey; M G Bernard
Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp).
Metabolism: clinical and experimental 1991;40(1):93-100.
1990: Rampratap S Kushwaha; David M Foster; Hugh Barrett; K Dee Carey
Effect of estrogen and progesterone on metabolism of apoprotein B in baboons.
The American journal of physiology 1990;258(1 Pt 1):E172-83.